MYOKARDIA INC's ticker is MYOK and the CUSIP is 62857M105. A total of 128 filers reported holding MYOKARDIA INC in Q3 2018. The put-call ratio across all filers is 0.36 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $443,000 | +41.5% | 3,251 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $313,000 | +103.2% | 3,251 | 0.0% | 0.00% | – |
| Q1 2020 | $154,000 | -34.5% | 3,251 | 0.0% | 0.00% | -100.0% |
| Q4 2019 | $235,000 | -18.4% | 3,251 | -43.5% | 0.00% | 0.0% |
| Q2 2019 | $288,000 | +32.7% | 5,750 | +37.3% | 0.00% | 0.0% |
| Q1 2019 | $217,000 | +10.2% | 4,188 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $197,000 | -7.5% | 4,188 | +27.8% | 0.00% | 0.0% |
| Q3 2018 | $213,000 | +30.7% | 3,276 | 0.0% | 0.00% | – |
| Q2 2018 | $163,000 | +96.4% | 3,276 | +92.7% | 0.00% | – |
| Q1 2018 | $83,000 | +16.9% | 1,700 | 0.0% | 0.00% | – |
| Q4 2017 | $71,000 | -1.4% | 1,700 | 0.0% | 0.00% | – |
| Q3 2017 | $72,000 | +227.3% | 1,700 | 0.0% | 0.00% | – |
| Q2 2017 | $22,000 | 0.0% | 1,700 | 0.0% | 0.00% | – |
| Q1 2017 | $22,000 | 0.0% | 1,700 | 0.0% | 0.00% | – |
| Q4 2016 | $22,000 | – | 1,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 399,360 | $54,445,000 | 40.54% |
| Copernicus Capital Management, LLC | 42,186 | $5,751,000 | 5.48% |
| Casdin Capital, LLC | 870,000 | $118,607,000 | 5.31% |
| Foresite Capital Management IV, LLC | 126,492 | $17,245,000 | 3.89% |
| Avoro Capital Advisors LLC | 1,885,000 | $256,982,000 | 3.65% |
| RTW INVESTMENTS, LP | 936,931 | $127,732,000 | 3.08% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 65,859 | $8,979,000 | 2.90% |
| Perceptive Advisors | 1,395,017 | $190,183,000 | 2.78% |
| Fernwood Investment Management, LLC | 38,547 | $5,255,000 | 2.48% |
| Grace Capital | 23,400 | $3,190,000 | 2.47% |